07/30/2026
The landscape of oncology care is shifting. A recent feature in Specialty Pharmacy Continuum highlights the expanding role of GLP-1 receptor agonists in managing metabolic health for oncology patients. As these therapies become a staple in comprehensive cancer care, the focus is turning toward shared decision-making and high-touch clinical oversight.
At CarepathRx, we are uniquely positioned to support this evolution. Our Home Infusion Solutions bring specialized oncology and metabolic support directly to the patient’s doorstep, ensuring safety and adherence without the hospital commute.
📖 Read the full article here:
The-evidence-behind-a-boxed-warning-for-thyroid-cancer-that-has-made-many-oncology-clinicians-wary-of-GLP-1-receptor-agonists-is-weaker-than-most-practitioners-realize-experts-said-at-HOPA-2026-in-New-Orleans-nbsp